rs34368092

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000431.4(MVK):​c.405G>A​(p.Ser135Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.048 in 1,614,080 control chromosomes in the GnomAD database, including 2,437 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.051 ( 285 hom., cov: 33)
Exomes 𝑓: 0.048 ( 2152 hom. )

Consequence

MVK
NM_000431.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12O:1

Conservation

PhyloP100: -4.38

Publications

14 publications found
Variant links:
Genes affected
MVK (HGNC:7530): (mevalonate kinase) This gene encodes the peroxisomal enzyme mevalonate kinase. Mevalonate is a key intermediate, and mevalonate kinase a key early enzyme, in isoprenoid and sterol synthesis. Mevalonate kinase deficiency caused by mutation of this gene results in mevalonic aciduria, a disease characterized psychomotor retardation, failure to thrive, hepatosplenomegaly, anemia and recurrent febrile crises. Defects in this gene also cause hyperimmunoglobulinaemia D and periodic fever syndrome, a disorder characterized by recurrent episodes of fever associated with lymphadenopathy, arthralgia, gastrointestinal dismay and skin rash. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]
MVK Gene-Disease associations (from GenCC):
  • porokeratosis 3, disseminated superficial actinic type
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • hyperimmunoglobulinemia D with periodic fever
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
  • mevalonate kinase deficiency
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • mevalonic aciduria
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)
  • disseminated superficial actinic porokeratosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • porokeratosis of Mibelli
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 12-109581428-G-A is Benign according to our data. Variant chr12-109581428-G-A is described in ClinVar as Benign. ClinVar VariationId is 129639.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-4.39 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0607 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000431.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MVK
NM_000431.4
MANE Select
c.405G>Ap.Ser135Ser
synonymous
Exon 5 of 11NP_000422.1Q03426
MVK
NM_001414512.1
c.405G>Ap.Ser135Ser
synonymous
Exon 5 of 12NP_001401441.1
MVK
NM_001114185.3
c.405G>Ap.Ser135Ser
synonymous
Exon 5 of 11NP_001107657.1B2RDU6

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MVK
ENST00000228510.8
TSL:1 MANE Select
c.405G>Ap.Ser135Ser
synonymous
Exon 5 of 11ENSP00000228510.3Q03426
MVK
ENST00000546277.6
TSL:5
c.405G>Ap.Ser135Ser
synonymous
Exon 5 of 11ENSP00000438153.2Q03426
MVK
ENST00000878306.1
c.405G>Ap.Ser135Ser
synonymous
Exon 5 of 11ENSP00000548365.1

Frequencies

GnomAD3 genomes
AF:
0.0512
AC:
7787
AN:
152146
Hom.:
285
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0394
Gnomad AMI
AF:
0.0615
Gnomad AMR
AF:
0.0306
Gnomad ASJ
AF:
0.0694
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.0110
Gnomad FIN
AF:
0.0916
Gnomad MID
AF:
0.0701
Gnomad NFE
AF:
0.0623
Gnomad OTH
AF:
0.0503
GnomAD2 exomes
AF:
0.0449
AC:
11281
AN:
251052
AF XY:
0.0448
show subpopulations
Gnomad AFR exome
AF:
0.0403
Gnomad AMR exome
AF:
0.0240
Gnomad ASJ exome
AF:
0.0641
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0861
Gnomad NFE exome
AF:
0.0584
Gnomad OTH exome
AF:
0.0505
GnomAD4 exome
AF:
0.0477
AC:
69725
AN:
1461814
Hom.:
2152
Cov.:
32
AF XY:
0.0477
AC XY:
34668
AN XY:
727218
show subpopulations
African (AFR)
AF:
0.0416
AC:
1394
AN:
33476
American (AMR)
AF:
0.0259
AC:
1160
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0636
AC:
1661
AN:
26132
East Asian (EAS)
AF:
0.000101
AC:
4
AN:
39700
South Asian (SAS)
AF:
0.0133
AC:
1151
AN:
86254
European-Finnish (FIN)
AF:
0.0876
AC:
4675
AN:
53394
Middle Eastern (MID)
AF:
0.0582
AC:
334
AN:
5742
European-Non Finnish (NFE)
AF:
0.0509
AC:
56571
AN:
1112002
Other (OTH)
AF:
0.0460
AC:
2775
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
4489
8979
13468
17958
22447
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1850
3700
5550
7400
9250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0512
AC:
7795
AN:
152266
Hom.:
285
Cov.:
33
AF XY:
0.0507
AC XY:
3776
AN XY:
74456
show subpopulations
African (AFR)
AF:
0.0395
AC:
1640
AN:
41570
American (AMR)
AF:
0.0306
AC:
468
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0694
AC:
241
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5178
South Asian (SAS)
AF:
0.0112
AC:
54
AN:
4816
European-Finnish (FIN)
AF:
0.0916
AC:
972
AN:
10614
Middle Eastern (MID)
AF:
0.0822
AC:
24
AN:
292
European-Non Finnish (NFE)
AF:
0.0623
AC:
4234
AN:
67998
Other (OTH)
AF:
0.0497
AC:
105
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
385
770
1156
1541
1926
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
86
172
258
344
430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0585
Hom.:
211
Bravo
AF:
0.0446
Asia WGS
AF:
0.00866
AC:
30
AN:
3478
EpiCase
AF:
0.0588
EpiControl
AF:
0.0528

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not specified (5)
-
-
3
not provided (4)
-
-
1
Autoinflammatory syndrome (1)
-
-
1
Hyperimmunoglobulin D with periodic fever (1)
-
-
1
Hyperimmunoglobulin D with periodic fever;C1867981:Porokeratosis 3, disseminated superficial actinic type;C1959626:Mevalonic aciduria (1)
-
-
1
Mevalonic aciduria (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.27
DANN
Benign
0.64
PhyloP100
-4.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34368092; hg19: chr12-110019233; COSMIC: COSV57331610; COSMIC: COSV57331610; API